Dimitrios Kapogiannis is a Clinician-Scientist who specializes in Behavioral Neurology, especially Alzheimer’s disease. He acquired his Medical Degree from the University of Athens Medical School, completed the Massachusetts General Hospital/Brigham and Women’s Hospital/Harvard Medical School Neurology residency training program and a Clinical Fellowship in Behavioral Neurology at the National Institute of Neurological Disorders and Stroke. He has been a Clinical Investigator at the National Institute on Aging since 2014, leading a lab that conducts basic, translational, biomarker and clinical studies in cognitive aging and Alzheimer's disease. He holds an adjunct appointment as Associate Professor at the Department of Neurology of Johns Hopkins University School of Medicine and provides clinical care at the Johns Hopkins Memory and Alzheimer's Treatment Center. He is widely recognized as an expert in the field of Extracellular Vesicle biomarkers in Neurology and has pioneered the use of neuronal-enriched Extracellular Vesicles for the clinical and preclinical diagnosis of Alzheimer’s disease and other neurodegenerative, neurological and psychiatric diseases.